U.S. Benign Prostatic Hyperplasia Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This research service covers the Benign Prostatic Hyperplasia Markets across the United States. The research service provides a detailed analysis of the revenue structure across therapies. Strategic recommendations for these have also been discussed along with revenue forecasts.

Table of Contents

U.S. Benign Prostatic Hyperplasia Markets, Executive Summary Executive Summary Executive SummaryU.S. Benign Prostatic Hyperplasia Markets, Introduction to Benign Prostatic HyperplasiaIntroduction to Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia OverviewScope and SegmentationBasic Benign Prostatic Hyperplasia Terminologies and DefinitionsBasic Benign Prostatic Hyperplasia TerminologyThe History of Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia DiagnosisBenign Prostatic Hyperplasia ComplicationsU.S. Benign Prostatic Hyperplasia Markets, U.S. Benign Prostatic Hyperplasia Market SegmentsDisease and Treatment OverviewBenign Prostatic Hyperplasia PrevalenceTreated Population ForecastUrologist and Primary Care Physician Practice PatternsProduct AnalysisOverviewMinimally Invasive TherapyWatchful Waiting and Medical TherapyAlpha Adrenergic Antagonists Therapy Alpha Reductase Inhibitor TherapyCombination TherapyU.S. Benign Prostatic Hyperplasia Markets, U.S. Benign Prostatic Hyperplasia MarketsCompetitive and Product AnalysisCompetitive LandscapeLandmark StudiesSWOT Analysis of Current MedicationsCompetitor ProfilesPipeline AnalysisAnticipated Launch DatesMarket ForecastsRevenue ForecastsPricing TrendsKey Patent ExpirationFrost & Sullivan AwardsMarketing Strategy Leadership of the Year AwardIndustry Innovation Advancement of the Year AwardTechnology Innovation of the Year AwardProduct Differentiation Innovation of the Year Award U.S. Benign Prostatic Hyperplasia Markets, AppendixDecision Support DatabasesPhysiciansUrologistsProstate Cancer IncidenceProstate Cancer MortalityTotal Population




Related Research

Release Date : 20-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.